ON
← Back to feed
Skin cancer is treated with a new method at the UKC Ljubljana
Slovenia🏛️ Politics5 days ago

Skin cancer is treated with a new method at the UKC Ljubljana

The University Clinical Center (UKC) in Ljubljana has implemented a new method for treating skin cancers called Mohs microsurgery, achieving a success rate of 99.6%. Slovenia became the sixth country in Europe to adopt this technique. The method involves immediately staining and examining removed tissue under a microscope to ensure complete removal of cancer cells before closing the wound, reducing the need for multiple visits and minimizing the risk of recurrence. This approach is particularly beneficial for tumors located at skin-mucosa junctions. The procedure, which takes the same amount of time as traditional methods, is now being performed on 70 patients, with plans to treat between 600 and 700 patients annually. The clinic aims to gain accreditation for this American-based method, making Ljubljana the only European city with such accreditation. The process requires a laboratory and surgical rooms located close to the outpatient facility.

The University Clinical Centre Ljubljana has introduced a groundbreaking method for treating skin cancer, marking a significant advancement in medical care within Slovenia. This new approach, known as Mohs micrographic surgery, has achieved a success rate of 99.6 percent in completely removing skin tumors. With this implementation, Slovenia has become the sixth European country to adopt this technique, which was first developed in the United States several decades ago. As of now, the clinic has already performed its 70th operation using this method, according to statements made during a press conference.

Traditionally, skin cancer surgeries involved excising the affected tissue, suturing the wound, and then sending the sample to a pathology laboratory for analysis. The results would determine whether the tumor had spread beyond the margins of the excision. If it had, additional procedures were required, often leading to multiple visits for the patient and increasing the risk of cancer spreading further. However, the new method allows for immediate microscopic examination of the removed tissue during the procedure itself. This means that once all tumor cells have been identified and removed, the surgeon can close the wound immediately, significantly reducing the need for follow-up visits and minimizing the risk of cancer recurrence.

This technique is particularly beneficial for skin cancers located on transitional areas between skin and mucous membranes, where traditional methods might require more extensive removal of healthy tissue. While the duration of the surgery remains similar to conventional techniques, the entire process—from initial excision to final closure—can be completed within a few hours. In contrast, patients undergoing traditional surgery often face long waiting periods, sometimes up to six months or more, before receiving their results and subsequent treatment.

The introduction of Mohs micrographic surgery in Ljubljana began three years ago with the first six patients. Last year, the number increased to 37 operations, and today marks the 70th such procedure. According to Dr. Aleksandar L. Krunić, a specialist in dermatovenereology and Mohs surgery who previously obtained accreditation for this method in Chicago, the goal is to perform between 600 and 700 operations annually. He emphasized the importance of obtaining international accreditation for the center, which would make Ljubljana the only city in Europe with such recognition.

Currently, the clinic operates with a dedicated laboratory team and two operating rooms. Krunić also mentioned plans for future expansion, including training young doctors to ensure the continued growth of the program. The integration of an accredited laboratory directly adjacent to the surgical suite is crucial for the successful execution of this method. This setup enables rapid processing of tissue samples and allows the Mohs surgeon to work closely with pathologists to assess the tumor's location and direction of spread in real-time, ensuring precise and efficient removal.

The dermatovenereal clinic in Ljubljana stands out as one of the rare institutions worldwide that combines both the surgical suite and the accredited laboratory under one roof. This unique configuration facilitates quick turnaround times for tissue analysis and provides surgeons with direct access to pathological insights, enhancing the precision of each procedure. According to Violeta Hosta, deputy head of the histopathological laboratory, this arrangement not only expedites the diagnostic process but also gives surgeons a tactile understanding of how much tissue needs to be removed in subsequent steps, contributing to better outcomes for patients.

As the clinic continues to refine and expand its use of Mohs micrographic surgery, it aims to establish itself as a regional hub for advanced skin cancer treatment. The anticipated increase in annual operations underscores the growing demand for this highly effective method, reflecting a broader trend towards adopting innovative medical practices that prioritize patient safety and efficiency. With ongoing efforts to train new specialists and secure international accreditation, the future looks promising for the continued success and expansion of this pioneering approach in Ljubljana.

How each side covered it

The same event, grouped by the political lean of the outlets covering it.

How each side covered it

Support independent, bias-aware news and unlock the social pulse, community voting, and your personalized For You feed.

Become a Supporter

Covered around the world

The same event as reported in other countries.

Covered around the world

Support independent, bias-aware news and unlock the social pulse, community voting, and your personalized For You feed.

Become a Supporter

Claims check

Key factual claims, and how many sources assert vs dispute each.

Claims check

Support independent, bias-aware news and unlock the social pulse, community voting, and your personalized For You feed.

Become a Supporter

2 reports

Lokalec logoLokalecIndependentCenterFactual 95Objective 855 days ago
Skin cancer is treated with a new method at the UKC Ljubljana

The University Clinical Center (UKC) in Ljubljana has implemented a new method for treating skin cancers called Mohs microsurgery, achieving a success rate of 99.6%. Slovenia became the sixth country in Europe to adopt this technique. The method involves immediately staining and examining removed tissue under a microscope to ensure complete removal of cancer cells before closing the wound, reducing the need for multiple visits and minimizing the risk of recurrence. This approach is particularly beneficial for tumors located at skin-mucosa junctions. The procedure, which takes the same amount of time as traditional methods, is now being performed on 70 patients, with plans to treat between 600 and 700 patients annually. The clinic aims to gain accreditation for this American-based method, making Ljubljana the only European city with such accreditation. The process requires a laboratory and surgical rooms located close to the outpatient facility.

Bias read (Center): The article presents information about a medical advancement without overtly promoting any political ideology. It focuses on clinical outcomes, patient care improvements, and institutional achievements, maintaining a balanced tone. There is no indication of ideological leaning toward either left or右

Why these scores (Factual 95 · Objective 85): The article provides detailed information about the new method at UKC Ljubljana, including quotes from Tanja Planinšek Ručigaj and specific figures like 99.6% success rate and 70 patients operated on. The facts align with the cross-source consensus, though some minor details may be omitted compared

Žurnal24 logoŽurnal24IndependentCenterFactual 93Objective 805 days ago
A major breakthrough at UKC Ljubljana: Skin tumours are now removed with almost 100% success

The University Clinical Center (UKC) in Ljubljana has introduced Mohs microsurgery, a highly effective method for removing skin tumors with a 99.6% success rate. This technique, originally developed in the United States, allows for immediate evaluation of tissue margins during surgery, reducing the need for multiple visits and minimizing cancer spread risk. The procedure is particularly beneficial for tumors located at skin-mucosa junctions. Slovenia has become the sixth country in Europe to adopt this method, with plans to perform between 600 and 700 operations annually. The UKC has already completed 70 procedures since implementing the method three years ago, aiming to establish Ljubljana as an European center for this treatment.

Bias read (Center): The article presents information about a medical advancement without overt ideological framing. It focuses on clinical outcomes, procedural benefits, and institutional goals without promoting specific political agendas or ideologies. While the topic relates to healthcare policy, the tone remains non

Why these scores (Factual 93 · Objective 80): This article also reports accurately on the introduction of Mohs microsurgery at UKC Ljubljana with a 99.6% success rate. It includes similar quotes and data as the first article but presents the information more briefly. The tone is slightly more promotional, affecting objectivity slightly.

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €5/month.

Become a Supporter

Related stories